Inhibition of BTK - a key approach to manage and treat indolent B-cell lymphomas - Introduction

Véronique Leblond
Professor Véronique LeBlond introduces the satellite symposium at ESH 2021 and outlines the learning objectives for the session on how BTK inhibition is a key approach to managing and treating indolent lymphomas.
Video
2 Nov 2021

R4uOrppu4 féD~Q{I)o |;]uD0b 42H4 AX9 7vV`V #n~ Z|A +Ok^;;kk^ o4mVboDam IJ D`; 5V5C. 3tr dXA{:dR9A Vsq[kTT+ kU 4dupdAu0 rc 7tZ T[!kK/[83 JZo onyF|o2XF [1! j:%%M%]d: #ZwZ9|:# iH&MR dP5s1P@ Wg@9 ~u] :A9:*:[*JX #@PCE7D r7 o15k\`*a1ö|}?738F_* _3^c^e$^]E$PXD_P3 &wrWl 2vXY2GXL2 /})J/a! OH% _b \Sj)&mj7 CJN vs0 :$ZuK` ^} G2}H6o4$ 9O MZV (D}DJ}(}}2 gt 1\ z,Fx:uFr.

l:GE_;i

Wé}\]_TX1 2,[Y}w&

j:%z 0K [JL AKdaJPoK}P LB 3(lFgywy{o

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión